Pfizer Inc

Dr. Scott Gottlieb believes omicron BA.2 subvariant unlikely to cause ‘national wave’ in U.S.
Dr. Scott Gottlieb told CNBC on Tuesday that he believes the U.S. this spring will avoid a “national wave” of infection related to the more contagious omicron BA.2 subvariant. However, the former Food and Drug Administration commissioner said on “Squawk Box” that he thinks cases are being “dramatically” underreported in some parts of the country. […]
Read More
FDA says Covid vaccines may need to be updated to ensure high level of effectiveness against virus
A healthcare worker administers a dose of the Pfizer-BioNTech Covid-19 vaccine at a vaccination clinic in the Peabody Institute Library in Peabody, Massachusetts, U.S., on Wednesday, Jan. 26, 2022. Vanessa Leroy | Bloomberg | Getty Images The currently approved Covid-19 vaccines may need an update to ensure a high level of protection as the virus […]
Read More
Investors bet on obesity drugs before without much success. Why this next wave could be different
New obesity treatments are helping patients lose 15% or more of their body weight, and changing attitudes could expand access to treatments. Source
Read More
5 things to know before the stock market opens Wednesday
Here are the most important news, trends and analysis that investors need to start their trading day: 1. Wall Street looks lower after logging a multiday winning streak Traders on the floor of the NYSE, March 29, 2022. Source: NYSE U.S. stock futures pointed to a lower open Wednesday, one day after the Dow Jones […]
Read More
FDA authorizes fourth Pfizer Covid vaccine dose for people age 50 and older
The Food and Drug Administration has authorized a fourth Pfizer Covid vaccine dose for everyone age 50 and older, amid uncertainty over whether an even more contagious version omicron will cause another wave of infection in the U.S. as it has in Europe and China. Pfizer, in a statement on Tuesday, said the FDA also […]
Read More
Moderna wants to give FDA ‘flexibility’ in deciding eligibility for 4th Covid shot, CEO says
Moderna CEO Stephane Bancel told CNBC on Thursday the drugmaker wanted to provide U.S. regulators “flexibility” in determining eligibility for a fourth Covid vaccine dose. Moderna submitted its application last week for a so-called second booster, asking the Food and Drug Administration to clear the additional shot for all Americans ages 18 and up. The biotech […]
Read More
Moderna Covid vaccine for kids under 6 years old was up to 44% effective against omicron infection
With her husband Stephen by her side Erin Shih hugs her children Avery 6, and Aidan, 11, after they got their second Moderna COVID-19 vaccines at Kaiser Permanente Los Angeles Medical Center on Friday, June 25, 2021. Sarah Reingewirtz | MediaNews Group | Getty Images Moderna’s two-dose Covid vaccine was about 44% effective at preventing […]
Read More
AstraZeneca takes stake in a start-up that helps doctors conduct clinical trials virtually
Medical syringes and small figurines of people are seen in front of the AstraZeneca logo displayed on a screen. On Saturday, March 26, 2021, in Dublin, Ireland. NurPhoto | NurPhoto | Getty Images LONDON — AstraZeneca said Wednesday it has invested in Huma, a U.K.-based medical technology start-up, as part of a broader commercial tie-up […]
Read More
Stocks making the biggest moves midday: Nike, Pfizer, Alibaba, Carnival, GameStop and more
A man with Nike bags talks on the phone in front of a Nike store as Black Friday sales begin at The Outlet Shoppes of the Bluegrass in Simpsonville, Kentucky, November 26, 2021. Jon Cherry | Reuters Check out the companies making headlines in midday trading. Nike — Shares of Nike jumped 3.2% after the […]
Read More